Interestingly, this research has pointed to the role of the gene coding for methylthioadenosine phosphorylase, often codeleted with p16 (CDKN2A), particularly in MM and several types of sarcomas [23]. The gene discussed is CDKN2A; the disease is Miyoshi myopathy.